Fast ‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: efficacy and safety from a randomized double‐blind trial

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - September 27, 2018 Category: Endocrinology Authors: John B. Buse, Anders L. Carlson, Mitsuhisa Komatsu, Ofri Mosenzon, Ludger Rose, Bo Liang, Kristine Buchholtz, Hiroshi Horio, Takashi Kadowaki Source Type: research